Clinical effect and tolerability of atorvastatin versus placebo in patients with Pulmonary
Hypertension: double-blinded, randomised, prospective phase II study for 6 months with
adjusted doses of Atorvastatin
Phase:
Phase 2
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborators:
Capital Development Scientific Fund National Grant from The Ministry of Science and Technology